Dermatology Patient Pathways (Guidelines)

Warning

 

For Dermatology Patient Pathways click here

The National Dermatology Patient Pathways should be used in association with drug recommendations and guidance in this section to inform the management of acne, alopecia, atopic eczema, benign skin lesions, generalised and local pruritus, hand and foot eczema, molluscum contagiosum, nail dystrophy, non-melanoma skin cancers, psoriasis, rosacea, scabies, solar (actinic) keratoses and Bowen’s Disease, suspicious pigmented lesions, urticaria, and viral warts.

Editorial Information

Last reviewed: 26/10/2021

Next review date: 31/10/2024

Author(s): Dermatology .

Version: 1

Reviewer name(s): Dr Fiona Meredith Clinical Lead for Dermatology .

Document Id: TAM480